Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) represented a move of -4.17 percent or $0.1 per share and closed its previous day trading session at $3.45. 800557 Shares were traded in the last trading session with an Average Volume of 690.35 Million Shares. The stock currently has a Market Capitalization of 120.03 Million.
Adamis Pharmaceuticals Corporation, formerly Cellegy Pharmaceuticals, Inc., is a specialty pharmaceutical company engaged engages in the research, development, and commercialization of prescription medicines for the treatment of viral infections. Adamis Pharmaceuticals is composed of two wholly owned subsidiaries, Adamis Labs and Adamis Viral Therapies. Adamis Labs is a commercial stage specialty pharmaceutical company targeting high-prescribing physicians in the allergy, respiratory and pediatric medicine market segments. To complement and add to the sales efforts of Adamis Labs, Adamis Viral Therapies is focused on the development of patented, highly-valued proprietary vaccine technology that Adamis believes has the potential to prevent or treat infections such as influenza or chronic hepatitis. Adamis also provides packaging for pharmaceutical and nutraceutical products. The company is headquartered in Del Mar, California.
The stock traded between $3.20 and $6.45 over 1-Year time period showing its price to sales ratio of 9.45. Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) is currently showing an DECREASING volatility over a period of 10-Days while the 20-Days Volatility showing a DECREASING trend.
Right now, the stock has a 50-Day Simple Moving Average of $-17.94 and 200-Day Simple Moving Average of $-25.4. Its Price to Free Cash Flow is 0 and Price to Book of 2.36.
Analyst’s recommended the stock as 2 where 1 represents Strong Buy and 5 represents Sell.
In the last Quarter, Adamis Pharmaceuticals Corporation (NASDAQ:ADMP) reported its Actual EPS of $-0.21/share. The analysts offering Earnings Estimates for the company were believing that Adamis Pharmaceuticals Corporation could bring EPS of $-0.16/share. The difference between Actual EPS and Estimated EPS was -0.05 Percent. Thus showing an Earnings Surprise of -31.2 Percent.
YRC Worldwide Inc. (NASDAQ:YRCW)
In the last trading session, YRC Worldwide Inc. (NASDAQ:YRCW) added its value by -0.98% closing at the price of $10.06. The stock currently has market capitalization of 329.19 Million, with average volume of 796.7 Million shares.
Beta is also a factor of measure of the relative volatility of a particular stock to the market. Currently YRC Worldwide Inc. (NASDAQ:YRCW) is showing beta of 4. This particular value of beta suggests that YRC Worldwide Inc. (NASDAQ:YRCW) has historically moved 400% for every 100% move in the benchmark, based on price level.
EPS is another important factor while making the decision of buying, selling or holding of particular share. Currently EPS for YRC Worldwide Inc. (NASDAQ:YRCW) is at $-0.35.
The stock currently has RSI of 26.51. RSI is considered overbought when above 70 and oversold when below 30, currently the given RSI for the stock suggests that the stock is average and it has not entered in overbought or oversold territory.
YRC Worldwide Inc., headquartered in Overland Park, Kan., is the holding company for a portfolio of less-than-truckload (LTL) companies including YRC Freight, YRC Reimer, Holland, Reddaway, and New Penn. Collectively, YRC Worldwide companies have one of the largest, most comprehensive LTL networks in North America with local, regional, national and international capabilities.
YRC Worldwide Inc. (NASDAQ:YRCW) topped its 52-week high price of $17.61 on 01/24/18 and 52-Week Low Price of $ 7.36 on 05/18/17. The Stock currently has P/E (price to earnings ttm) of 0 and Weekly volatility of 6.37% and monthly volatility of 6.03% respectively.